Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 300 for “"payers"”.

  1. Transfer pricing model for tax payers and tax administrators /

    … This model can be applied by the tax payers who needs to determine the arm’s length transfer prices in practise (e.g. for sale of goods, provision of services, loans and other inter-company transactions) and for tax administrators who are controlling the compliance of transfer prices …

    vilnius Repository record for Transfer pricing model for tax payers and tax administrators / (opens in a new tab)

  2. Are Risk-takers Dividend Payers? CEO Compensation and its Impact on Dividend Decision

    Both dividend policy and CEO risk aversion have been subjects of tremendous research over the past 30 years. The current gap is how both topics are sporadically considered in tandem. We provide a solution to this by analyzing dividend changes in the context of CEO risk-taking incentives. Our …

    sask Repository record for Are Risk-takers Dividend Payers? CEO Compensation and its Impact on Dividend Decision (opens in a new tab)

  3. Comparison of the approval process between private and public payers in hematopoietic stem cell transplantation

    Objectives: The increased use of hematopoietic stem cell transplant (HSCT) for its potentially curative properties has led to studies examining the quality of care that is currently received. More specifically, research examining the timeliness aspect of quality of care is being addressed. This …

    bu Repository record for Comparison of the approval process between private and public payers in hematopoietic stem cell transplantation (opens in a new tab)

  4. A Time Study of Audiological Practice Patterns and the Impact of Reimbursement Changes from Third Part Payers

    The primary objective of the project was to survey audiologists in clinical practice setting to determine the amount of time taken to perform various audiologic tests using Current Procedural Terminology, (CPT) codes to define these tests and if these CPT codes were felt to be adequate. …

    usf Repository record for A Time Study of Audiological Practice Patterns and the Impact of Reimbursement Changes from Third Part Payers (opens in a new tab)

  5. Proposals for Updating the Canadian Patented Medicine Prices Review Board Pharmaceutical Budget Impact Analysis Guidelines for New Drug Submissions to Public and Private Payers

    … of expert opinions, data extrapolated from the payers’ database, scenario analysis, and dynamic population. Thirty percent of the recommendations, such as off-label indications in the base-case scenario, indirect costs, and cost transfers from other jurisdictions, were not supported by …

    mcmaster Repository record for Proposals for Updating the Canadian Patented Medicine Prices Review Board Pharmaceutical Budget Impact Analysis Guidelines for New Drug Submissions to Public and Private Payers (opens in a new tab)

  6. Comparing how Medicare Part D sponsors and commercial third-party payers calculate prescription reimbursement rates and the subsequent impact on the financial viability of independent pharmacies in Texas

    … Part D sponsors and commercial third-party payers, resulting in decreased gross margins for independent pharmacies; however, reports are inconclusive regarding which payer more greatly affects independent pharmacies’ financial viability. Using 2006-2009 prescription claims data collected by …

    texas Repository record for Comparing how Medicare Part D sponsors and commercial third-party payers calculate prescription reimbursement rates and the subsequent impact on the financial viability of independent pharmacies in Texas (opens in a new tab)

  7. Profitability Premium Puzzle and Investors' Behavioral Mistakes

    … into two groups: dividend and non-dividend payers and hypothesize that profitability premium may only exist among the firms with unforeseeable future cash flows, i.e., non-dividend payers. As expected, my empirical results support that profitability premium only exists among non-dividend …

    unt Repository record for Profitability Premium Puzzle and Investors' Behavioral Mistakes (opens in a new tab)

  8. Institutional Investor Heterogeneity and the Information Content of Dividends

    … effect is stronger and concentrated in bottom payers. Furthermore, the change of holdings owned by institutional investors with different incentive to monitor a firm's governance has distinct effects on the decline of information content across top and bottom payers. Our results indicate that …

    concordia Download PDF for Institutional Investor Heterogeneity and the Information Content of Dividends (opens in a new tab)

  9. Dividend Policy, Stock Liquidity and Stock Price Informativeness

    … We show that, on average, stocks of dividend payers have significantly lower bid–ask spread and a lower illiquidity ratio than their counterparts of non-dividend payers. We also find that stocks of high-dividend payers are more liquid than those of firms that pay low or no dividends. These …

    bradford Repository record for Dividend Policy, Stock Liquidity and Stock Price Informativeness (opens in a new tab)

  10. Two Essays on Forced CEO Turnover During Envy Merger Waves, and Dividends

    … towards dividend paying-firms. We find that payers outperform non-payers during the financial crisis. Further, the results document that non-payers with buybacks outperform non-payers with no buybacks. This indicates that payouts can function as an insurance mechanism for investors, and this …

    odu Repository record for Two Essays on Forced CEO Turnover During Envy Merger Waves, and Dividends (opens in a new tab)

  11. Information in Financial Markets

    … of information asymmetry in alleviating dividend payers’ seasoned equity offering (SEO) announcement returns, the leading behavior of equity analysts who collect and process information, and the pricing of productivity-related information. More specifically, Chapter 1 studies whether the market …

    toronto-retro Repository record for Information in Financial Markets (opens in a new tab)

  12. Behaviour in a Canadian Multi-payer, Multi-provider Health Care Market: The Case of the Physiotherapy Market in Ontario

    … involving the interaction of public and private payers and for-profit (FP) and not-for-profit (NFP) providers; the influence of health professionals on market structure; and the role of foreign investment. A case study was used, the Ontario physiotherapy market in 2003-2005, with its complex mix …

    toronto-retro Repository record for Behaviour in a Canadian Multi-payer, Multi-provider Health Care Market: The Case of the Physiotherapy Market in Ontario (opens in a new tab)

  13. A Stakeholder-Informed Conceptual Framework for Evaluating Genomics in Precision Oncology

    … in precision oncology with an emphasis on how US payers conceptualize and prioritize elements of value. This research aims to address gaps in understanding payer perspectives and proposes a stakeholder-informed framework for evaluating genomic testing in oncology. To achieve this aim, the …

    clemson Repository record for A Stakeholder-Informed Conceptual Framework for Evaluating Genomics in Precision Oncology (opens in a new tab)

  14. Didesnio tarifo mokestis Lietuvos apmokestinimo sistemoje /

    … legal regulation provided by laws for tax payers in different situations does not constitute discrimination but is justified in pursuit of public welfare and the implementation of specific economic and social goals. The thesis highlights the necessity of tax collection for the …

    vilnius Repository record for Didesnio tarifo mokestis Lietuvos apmokestinimo sistemoje / (opens in a new tab)

  15. Payer Perspectives On Preemptive Pharmacogenetic Testing

    … pharmacogenetic testing of third-party payers. Methods: A qualitative study utilizing a blended inductive and directed approach was conducted. A screener survey determined interview eligibility as well as demographic data. Semi-structured interviews were conducted with payers from …

    mississippi Repository record for Payer Perspectives On Preemptive Pharmacogenetic Testing (opens in a new tab)

  16. Assessing the Impact of Health Economics and Outcomes Research Evidence on Reimbursement Decisions in the United States

    … types of HEOR evidence are important to U.S. payers and tested these hypotheses in a survey of HEOR decision-makers in pharmaceutical companies and formulary decision-makers for payer organizations. Results: Previous studies suggest a growing importance of HEOR evidence in U.S. reimbursement …

    washington Repository record for Assessing the Impact of Health Economics and Outcomes Research Evidence on Reimbursement Decisions in the United States (opens in a new tab)

  17. Exploring the uptake of value-based formulary strategies and their application to specialty drugs

    … increase drug adherence, and be cost neutral for payers when applied to many traditional drugs, such as antihypertensive and antihyperlipidemic therapies. It is unclear whether these same outcomes could be achieved if VBF strategies were applied to other drugs, such as specialty drugs. Specialty …

    washington Repository record for Exploring the uptake of value-based formulary strategies and their application to specialty drugs (opens in a new tab)

  18. CORPORATE MORAL HAZARD IN U.S. HEALTH INSURANCE: CHURN AND DENIAL RATES

    … misalignment, and may shift costs between payers. I test whether commercial payers, anticipating disenrollment, tighten adjudication in ways consistent with what I define in this context as corporate moral hazard. If so, denial rates should rise just before the switch to Medicare. …

    maryland Repository record for CORPORATE MORAL HAZARD IN U.S. HEALTH INSURANCE: CHURN AND DENIAL RATES (opens in a new tab)

  19. Market potential for pork products with embedded environmental attributes: an experimental approach

    … attributes. The average premium paid by premium payers under both measures ranged from 1.62 to 2.23 for the package with all three embedded environmental attributes. Statistical methods were used to examine whether there were differences in premiums with differing levels of embedded environmental …

    iastate Repository record for Market potential for pork products with embedded environmental attributes: an experimental approach (opens in a new tab)

  20. Value-based real option analysis to support early-stage drug development

    … analysis based a Markov model assuming a US payers’ willingness to pay (WTP, λ) of $50,000 per quality-adjusted life year (QALY) and payers’ discount rate (rd) of 3%. The drug candidate’s target product profile (TPP) was based on clinician reports on meaningful health improvements. 2. ROA via …

    ubc Repository record for Value-based real option analysis to support early-stage drug development (opens in a new tab) Download PDF for Value-based real option analysis to support early-stage drug development (opens in a new tab)

Page 1 of 15